Why in News?
Recently, Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) reached a significant milestone, with Janaushadhi medicines worth Rs. 1,000 crore sold in the year 2024-25 till October 2024.
Generic drugs are marketed under a non-proprietary or approved name rather than a proprietary or brand name. Generic drugs are equally effective and inexpensive compared to their branded counterparts.
Pharma & Medical Bureau of India (PMBI) was earlier called as Bureau of Pharma PSUs of India (BPPI).
Janaushadhi Kendras (JAKs) are accessible points for quality healthcare, providing a friendly environment where individuals can find the medications they need.
xielili588 3 days
While the idea is great, I wonder about the long-term sustainability and quality control. How are they ensuring consistent supply and dispelling public mistrust about generic drugs? These are crucial aspects for the program's ultimate success. By the way,When you need to reduce stress, you can play doodle baseball.